FP33-WE-02 Efficacy of natalizumab in second-line therapy...

FP33-WE-02 Efficacy of natalizumab in second-line therapy of relapsing remitting multiple sclerosis: results from a multi-center study in German speaking countries

N. Putzki, Y. Oezguer, M. Mäurer, S. Cursiefen, S. Kuckert, V. Limmroth, M. Maschke, B. Tettenborn
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
285
Year:
2009
Language:
english
DOI:
10.1016/s0022-510x(09)70440-x
File:
PDF, 47 KB
english, 2009
Conversion to is in progress
Conversion to is failed